Global Hunter Initiates MR With Buy
Analysts at Global Hunter Securities initiate coverage of Mindray Medical International Limited (NYSE: MR) with a "buy" rating. The target price for MR is set to $38.
MR’s shares fell 3.18% to close at $31.06 yesterday. More Analyst Ratings here
Learn how to find the best stocks to trade each day in our 70 page E-Book and 90 minute online video for free.







